Evidence Hub

Prematür ejakülasyona güncel yaklaşım

Burak Köseoğlu, Özer Güzel, Ali Atan

Androloji Bülteni, 2023

Abstract

Premature ejaculation (PE) is the most common ejaculation disorder affecting all age groups. It is a clinical condition that causes psychological stress and loss of self-confidence in the patient and has a negative effect on quality of life. While the main treatment of primary PE is pharmacotherapy, treatment of the underlying secondary causes may be more important in acquired PE. Behavioral treatments should be used in the initial phase and accompany pharmacological treatments. Pharmacological agents that can be used in the treatment of PE are selective serotonin reuptake inhibitors (SSRI), topical anesthetics, tramadol, tricyclic antidepressants (TCA), phosphodiesterase-5 inhibitors (PDE5i), α-1 blockers and some combinations of these. Invasive interventions are experimental and not recommended by the guidelines. Patient and partner compatibility can be said to be the most important factor that brings success in treatment. Keywords: men, premature ejaculation, treatment

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free